Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes

Overview of attention for article published in Critical Care, June 2019

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,133 followers.

Individualized recombinant human thrombomodulin (ART-123) administration in #sepsis patients based on predicted phenotypes @Crit_Care | #ECM https://t.co/ZoYpl6xylH

Individualized recombinant human thrombomodulin (ART-123) administration in #sepsis patients based on predicted phenotypes @Crit_Care | #ECM https://t.co/Ro85FaW831

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.